Journals / Türkderm-Deri Hastalıkları ve Frengi Arşivi / 2004 / Cilt: 38 - Sayı: 2

Hyperandrogenism and polycstic ovary syndrome in 59 women with androgenetic alopecia

Androgenetik alopesili 59 kadın hastada hiperandrojenizm ve polikistik over sendromu

Pages
106–110
Publication Date
2022-11-05
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

In this respect, every patient with AGA must be evaluated about hyperandrogenemia and PCOS.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Background and design: Androgenetic alopecia (AGA) is an androgen dependent and genetically mediated type of alopecia.
📊
Key Findings & Data:In this study, the percentages of other androgen dependent symptoms and PCOS were detected in women with AGA.
💡
Conclusion & Impact:In this respect, every patient with AGA must be evaluated about hyperandrogenemia and PCOS.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Background and design: Androgenetic alopecia (AGA) is an androgen dependent and genetically mediated type of alopecia. It is the most frequent cause of hair loss. Androgen mediated symptoms such as seborrhea; acne, hirsutism and AGA may be related to polycystic ovary syndrome (PCOS) in women. In this study, the percentages of other androgen dependent symptoms and PCOS were detected in women with AGA. Materials and methods: This study included 59 women between the ages of 16-40 with AGA. Dermatological and gynecological examination and pelvic ultrasound were performed. Serum glucose, lipids, liver and kidney function tests and hormonal tests were measured. Results: Hirsutism was present in 40%, acne in 20%, and seborrhea in 25%, and PCOS in 37% of 59 women with AGA. Some patients had dyslipidemia and some had hyperandrogenism. Conclusion: Androgen dependent symptoms were important in AGA patients. The most important coincidence with AGA is hirsutism. Although hormonal profile showed minimal abnormalities in our patient groups, PCOS incidence was higher. In this respect, every patient with AGA must be evaluated about hyperandrogenemia and PCOS.

Özet

Androgenetik alopesi hem erkek hem de kadınlarda en sık saç kaybı nedenidir. Gelişiminde genetik faktörler ve androjenler sorumludur. Hirsutizm, akne, sebore gibi diğer hiperandrojenemik bulgular ve hormonsal değişikliklerle birlikte görülebilir. Polikistik over sendromu kadınlardaki en sık hiperandrojenemi sebebidir. Biz çalışmamızda androgenetik alopesili kadınlarda hiperandrojenemik diğer bulguları, hormonsal ve metabolik değişiklikleri ve ayrıca polikistik over sendromunu araştırdık. Hirsutizm %40, akne %20, sebore %25 oranında saptandı. Bazı hastalarda androjen ve lipid değerlerinde yükselme görüldü. Klinik olarak hastaların %37’sine polikistik over sendromu tanısı konuldu. Sonuç olarak kadınlarda androgenetik alopesi, hiperandrojenemi ve hiperandrojenemik bulgularla birlikte olabilir bu amaçla polikistik over sendromu gibi hormonsal nedenler araştırılmalıdır.

🔖

Cite This Article

UTAŞ, S., UKŞAL, Ü., MÜDERRİS, İ., BORLU, M., BAYRAM, F. (2022). Hyperandrogenism and polycstic ovary syndrome in 59 women with androgenetic alopecia. Türkderm-Deri Hastalıkları ve Frengi Arşivi, Cilt: 38 - Sayı: 2, 106–110. https://ajindex.com/articles/622252

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (19)

  1. Tosti A, Camacho-Martinez F, Dawber R: Management of androgenetic alopecia. JEADV 1999; 12: 205-214
  2. Olsen EA: Female pattern hair loss. J Am Acad Dermatol 2001; 45 (3): 70-80
  3. Ellis JA, Sinclair R, Harrap SB: Androgenetic alopecia: pathogenesis and potential for therapy. Expert Rev Mol Med. 2002; 4: 1-11
  4. Shum KW, Cullen DR, Messenger AG: Hair loss in women with hyperandrogenism: four cases responding to finasteride. J Am Acad Dermatol. 2002; 47 (5): 733-741
  5. Whiting DA: Possible mechanism of miniaturization during androgenetic alopecia or pattern hair loss. J Am Acad Dermatol 2001; 45 (3): 81-86
  6. Chartier MB, Hoss DM, Grant-Kels JM: Approach to the adult female patient with diffuse nonscarring alopecia. Am Acad Dermatol. 2002 Dec;47(6):809-18; quiz 818-20
  7. Trueb RM, Wyss M, Itin PH: Androgenetic alopecia, hirsutism and hypertrichosia. Ther Umsch 1999; 56 (4): 219-242
  8. Davis S: Syndromes of hyperandrogenism in women. Aust Fam Physician 1999; 28 (5): 447-497
  9. Redmond GP: Androgens and women’s health. Int J Fertil Womens Med 1998; 43 (2): 91-97
  10. Orfanos CE, Adler YD, Zoubolis CC: The SAHA syndrome. Horm Res 2000; 54 (5-6): 251-258
  11. Knochenhauer ES, Key TJ, Kahsar-Miller M, Waggoner W, Boots LR, Azziz R: Prevalence of the Polycystic Ovary Syndrome in Unselected Black and White Women of the Southeastern United States: A Prospective Study. The Journal of Clinical Endocrinology & Metabolism Vol. 1998; 83: 3078-3082
  12. Futterweit W: Polycystic ovary syndrome: clinical perspectives and management. Obstet Gynecol Surv. 1999;54 (6): 403-415
  13. Rittmaster RS: Antiandrogen treatment of polycystic ovary syndrome. Endocrinol Metab Clin North Am 1999; 28 (2): 409-429
  14. Pasquali R, Casimirri F, Venturoli S, Antonio M, Morselli L, Reho S, Pezzoli A, Paradisi R: Body fat distribution has weight-independent effects on clinical, hormonal, and metabolic features of women with polycystic ovary syndrome. Metabolism. 1994; 43 (6): 706- 13
  15. Ludwig E. Classification of the types of androgenetic alopecia (common baldness) occurring in the female sex. Br J Dermatol 1977;97:247-8
  16. Ferriman D, Gallwey JD. Clinical assessment of body hair growth in women. J Clin Endocrinol Metab. 1961; 21:1440–8
  17. Burke BM, Cunliffe WJ. The assessment of acne vulgaris- the Leds technique. Br J Dermatol 1984; 111: 83-10
  18. Price WH: Androgenetic alopecia in women. Investig Dermatol Symp Proc. 2003; 8 (1):24-30
  19. Kaufman KD: Androgens and alopeci